| PERIOD ENDING | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | 30-Sep-07 | | Total Revenue | 2,029 | 2,153 | 3,087 | 2,553 | | Cost of Revenue | 826 | 840 | 2,919 | 120 | | | Gross Profit | 1,203 | 1,313 | 168 | 2,433 | | | Operating Expenses | | Research Development | 2,771 | 2,373 | 703 | 3,405 | | Selling General and Administrative | 2,053 | 2,618 | 2,126 | 1,716 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,621) | (3,678) | (2,661) | (2,688) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,012 | 375 | 3,003 | 779 | | Earnings Before Interest And Taxes | (2,609) | (3,303) | 342 | (1,909) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (2,609) | (3,303) | 342 | (1,909) | | Income Tax Expense | 754 | 8 | 1,833 | 688 | | Minority Interest | 85 | 124 | 40 | 116 | | | | Net Income From Continuing Ops | (3,278) | (3,187) | (1,451) | (2,481) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,278) | (3,187) | (1,451) | (2,481) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,278) | ($3,187) | ($1,451) | ($2,481) |
|
1.49% Nasdaq 
0.27%
Income Statement
